Literature DB >> 32202925

The TERT rs2736100 Polymorphism and Susceptibility to Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis.

Tao Hong1, Mei Luo2, Qi Liu3.   

Abstract

Introduction: The classification of myeloproliferative neoplasms (MPN) is currently based on the genotype. Thus, to achieve better diagnostic and prognostic outcomes, it is necessary to further investigate the genetic spectrum underlying the pathogenesis of MPNs. The rs2736100A>C is a functional single nucleotide polymorphism in the telomerase reverse transcriptase (TERT) gene that has been previously reported to be associated with the risk of MPNs. Herein, we performed a meta-analysis to confirm the relationship between the TERT rs2736100A>C polymorphism and MPN susceptibility. Materials and
Methods: Studies of case-control design were acquired from online databases with specific inclusion criteria. Odds ratios (ORs) with 95% confidence intervals (95% CI) were estimated to evaluate the association between the TERT rs2736100 polymorphism and MPN susceptibility using different genetic models.
Results: Ten case-control studies involving 3488 cases and 57,948 controls were examined. Overall, there was a significant association between the TERT rs2736100 polymorphism and the risk of MPNs (allele model [C vs. A]: OR = 1.57 [95% CI: 1.47-1.69]; homozygous model [CC vs. AA]: OR = 3.00 [95% CI: 2.40-3.76]; heterozygous model [AC vs. AA]: OR = 2.17 [95% CI: 1.77-2.66]; dominant model [CC+AC vs. AA]: OR = 2.43 [95% CI: 2.00-2.95]; and recessive model [CC vs. AC+AA]: OR = 1.73 [95% CI: 1.47-2.04]). Conclusions: In this meta-analysis, we confirm an association between the TERT rs2736100A>C polymorphism and MPN susceptibility under all genetic models evaluated. The TERT rs2736100A>C allele increases the overall risk of MPN. Further studies are warranted to determine the functional role of the TERT rs2736100 polymorphism in MPN.

Entities:  

Keywords:  TERT; myeloproliferative neoplasms; polymorphism; rs2736100

Mesh:

Substances:

Year:  2020        PMID: 32202925     DOI: 10.1089/gtmb.2019.0277

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  2 in total

Review 1.  TERT-Regulation and Roles in Cancer Formation.

Authors:  Marta Dratwa; Barbara Wysoczańska; Piotr Łacina; Tomasz Kubik; Katarzyna Bogunia-Kubik
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

2.  TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia.

Authors:  Marta Dratwa; Barbara Wysoczańska; Aleksandra Butrym; Piotr Łacina; Grzegorz Mazur; Katarzyna Bogunia-Kubik
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.